Document Detail


Comparison of age of onset and development of motor complications between smokers and non-smokers in Parkinson's disease.
MedLine Citation:
PMID:  15792818     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: There is growing evidence from case-control and from cohort studies that smoking is inversely related to the risk of developing Parkinson's disease (PD). However, it is still controversial if PD starts at an older age in ever-smoking patients compared to never-smoking ones. PATIENTS AND METHODS: The present retrospective study compares in a large series of 512 out-patients, collected over the last 24 years, the age of onset of the complaints, the age at which PD was diagnosed and the start of levodopa treatment between ever- and never-smokers. Also, the occurrence of long-term side-effects of the drug was evaluated. 184 PD patients with a history of smoking were compared with 328 who had never smoked. The subgroups with and without a family history of PD were analysed separately. RESULTS: In the overall ever-smoking group, as well as in the subgroup without a family history, the onset of the disease and the time of the diagnosis of PD and the time at which levodopa was started occurred at an older age than in the never-smoking group. This difference could not be demonstrated in the patients with a family history, due to the low number of cases and the lack of statistical power. Although the follow-up period was the same in both study groups, motor fluctuations and dyskinesia were more frequent and appeared earlier after levodopa treatment in the non-smoking compared to the ever-smoking PD patients. Only for cognitive impairment there was a non-significant trend in the smoking group. CONCLUSION: The present study confirms the protective action of smoking on PD and also suggests some modulating effect of smoking on the dopaminergic system.
Authors:
J De Reuck; M De Weweire; G Van Maele; P Santens
Related Documents :
309708 - Natural history and life expectancy in severe alpha1-antitrypsin deficiency, pi z.
10997828 - Coffee consumption and decreased serum gamma-glutamyltransferase: a study of middle-age...
3484908 - Longitudinal patterns of cigarette smoking and smokeless tobacco use in youth: the boga...
10711768 - Hemorheological aspects in hypertensive menopausal smoker women treated with female hor...
7056868 - Brain-age quotients in recently detoxified alcoholic, recovered alcoholic and nonalcoho...
19379798 - Sex recognition by male andrew's toad bufo andrewsi in a subtropical montane region.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of the neurological sciences     Volume:  231     ISSN:  0022-510X     ISO Abbreviation:  J. Neurol. Sci.     Publication Date:  2005 Apr 
Date Detail:
Created Date:  2005-03-28     Completed Date:  2005-06-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375403     Medline TA:  J Neurol Sci     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  35-9     Citation Subset:  IM    
Affiliation:
Department of Neurology, University Hospital, De Pintelaan 185, B-9000 Ghent, Belgium. jacques.dereuck@yucom.be
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Age of Onset*
Aged
Antiparkinson Agents / therapeutic use
Case-Control Studies
Cognition Disorders / drug therapy,  physiopathology
Cohort Studies
Dyskinesia, Drug-Induced / physiopathology
Female
Human Development
Humans
Levodopa / therapeutic use
Male
Middle Aged
Movement Disorders / drug therapy,  epidemiology*,  physiopathology*
Parkinson Disease / drug therapy,  epidemiology*,  physiopathology*
Smoking* / adverse effects
Time Factors
Chemical
Reg. No./Substance:
0/Antiparkinson Agents; 0/Levodopa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cogni...
Next Document:  Serum uric acid levels and leukocyte nitric oxide production in multiple sclerosis patients outside ...